✦ LIBER ✦

Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-ĸB)

✍ Scribed by Jessica Godek; Irene Sargiannidou; Sneha Patel; Lauren Hurd; Vicki L. Rothman; George P. Tuszynski

Book ID: 113956729
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 737 KB
Volume: 90
Category: Article
ISSN: 0014-4800
DOI: 10.1016/j.yexmp.2011.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1063 EPIDERMAL GROWTH FACTOR INDUCES BLA

1063 EPIDERMAL GROWTH FACTOR INDUCES BLADDER CANCER CELL PROLIFERATION THROUGH ACTIVATION OF ANDROGEN RECEPTOR

✍ Izumi, Koji; Zheng, Yichun; Zaengle, Jacqueline; Li, Yi; Miyamoto, Hiroshi 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Genistein enhances the effect of epiderm

Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines

✍ Shirish M. Gadgeel; Shadan Ali; Philip A. Philip; Antoinette Wozniak; Fazlul H. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

RETRACTED: Nuclear factor kappa B (NFκB)

RETRACTED: Nuclear factor kappa B (NFκB) dependent modulation of Epstein–Barr virus latent membrane protein 1 (LMP1) in epidermal growth factor receptor (EGFR) promoter activity

✍ Yong-guang Tao; Yun-nian Tan; Yi-ping Liu; Xin Song; Liang Zeng; Huang-hua Gu; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Relationship of epidermal growth factor

Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients

✍ H. KOUTSELINI; CH. MARKOPOULOS; S. LAMBROPOULOU; H. GOGAS; CH. KANDARAKI; J. GOG 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Concurrent inhibition of NF-κB, cyclooxy

Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer

✍ Shadan Ali; Sanjeev Banerjee; Jacqueline M. Schaffert; Bassel F. El-Rayes; Phili 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

## Abstract Inactivation of survival pathways such as NF‐κB, cyclooxygenase (COX‐2), or epidermal growth factor receptor (EGFR) signaling individually may not be sufficient for the treatment of advanced pancreatic cancer (PC) as suggested by recent clinical trials. 3,3′‐Diindolylmethane (B‐DIM) is

The effect of survivin on multidrug resi

The effect of survivin on multidrug resistance by epidermal growth factor receptor 2 via NF-κB activating in breast cancer cells

✍ Ren Kui Ding; Wei Ding; Cheng Kun Wang; Hui Lu; Zhi Min He 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 43 KB